All Search Results
-
Imperforate Anus
Imperforate anus is a congenital (present at birth) anorectal disorder that prevents a child from having normal bowel movements. Also known as anorectal malformation, this condition causes the opening of the anus to be too small, located in an unusual location or missing.
-
Meconium Ileus
Meconium is the sticky, tar-like material that newborns pass as their first bowel movement. Healthy babies pass meconium within their first day of life. Babies with meconium ileus have meconium that is even stickier and thicker than usual. This can cause bowel blockage. Most babies born with meconium ileus also have cystic fibrosis, which affects the lungs and pancreas.
-
Patient & Family Counseling
Learn more about how our licensed counselors work with patients of all ages and their families to provide healthcare intervention and support.
-
Pediatric Hepatology Clinic
In conjunction with a pediatric hepatologist, this clinic provides coordination and management of liver disorders.
-
Pediatric Emergency and Trauma Care
Our specialized physicians are on standby 24 hours a day, every day, to care for children experiencing medical emergencies.
-
Pediatric Pulmonary and Sleep Medicine
Pulmonary and Sleep Medicine provides an interdisciplinary approach to care for patients with chronic and acute respiratory disorders.
-
Pediatric Cochlear Implants
The cochlear implant team evaluates children with hearing impairment who may be candidates for a cochlear implant.
-
Kia Small, MSN, CPNP-AC
Kia Small is a certified pediatric nurse practitioner in acute care (CPNP-AC) with The Haley Center for Children's Cancer and Blood Disorders at Orlando Health Arnold Palmer Hospital for Children. She focuses primarily on providing care for patients diagnosed with sickle cell disease who require chronic transfusions. She is able to perform a variety of procedures, including:
-
Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) with Moderately to Severely Active Crohn's Disease
A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab with Open-Label Induction, Randomized
-
A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients from 1 Year to Less Than 18 Years Old Hospitalized with COVID-19
A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients from 1 Year to Less Than 18 Years Old Hospitalized
